TrialOncotarget2016

Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: results from the ITACa trial.

Andrea Casadei Gardini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.